Tech & Innovation 5 mins to read BioOra gains A$7.7m in backing from Queensland state govt The investment will help the Kiwi biotech company fit out a Queensland manufacturing site for its novel Car T-cell therapy. Fiona Rotherham Mon, 22 Jun 2026 © All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription. The Queensland state government says it has lured New Zealand-based biotech company BioOra to Brisbane through its flagship A$180.6 million Sovereign Industry Development
Fund (SIDF). BioOra will get A$7.7m ($9.4m) from the fund to establish and fit out its automated clinical and commercial-scale Want to read more? It’s easy. Choose your subscription Already have an account? Login Smartphone Only Subscription NZ$29.95 / monthly Monthly Premium Online Subscription NZ$49.95 / monthly Smartphone Only Annual Subscription NZ$299.00 / yearly Yearly Premium Online Subscription NZ$499.00 / yearly Premium Group Membership 10 Users NZ$385+GST / monthly $38.5 per user – Pay by monthly credit card debit Premium Group Membership 20 Users NZ$660+GST
/ monthly $33 per user – Pay by monthly credit card debit Premium Group Membership 50 Users NZ$1375+GST / monthly $27.5 per user – Pay by monthly credit card debit Premium Group Membership 100 Users NZ$2100+GST / monthly $21 per user – Pay by monthly credit card debit Yearly Premium Online Subscription + NBR Marketplace NZ$999.00 / yearly Individual Group membership NBR Marketplace Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499). View terms and conditions. Fiona Rotherham Mon,
22 Jun 2026 Contact the Writer: fiona@nbr.co.nz News tip? Question? Typo? Let us know: editor@nbr.co.nz © All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription. CAR T-cell therapy capital raise Queensland state government Free News Alerts Sign up to get the latest stories and insights delivered to your inbox – free, every day. Related News Tech & Innovation BioOra signs new global rights deal ahead of $30m fund raise Tech & Innovation More cancer patients
likely to benefit from new BioOra deal Tech & Innovation Biotech company BioOra triples its valuation in latest raise Tech & Innovation The US tycoons who ‘fell in love’ with New Zealand Tech & Innovation Cancer treatment company BioOra secures $4m funding to scale up
BioOra, Queensland, Sovereign Industry Development Fund, SIDF, Brisbane, Car T-cell therapy, biotech, manufacturing site, automated production, clinical and commercial-scale